Investing Profile

Andrew Schiff

VC

Photo of Andrew Schiff, Managing Partner at Aisling Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Aisling Capital Managing Partner
7
$280M
CompanyStageDateRound SizeTotal Raised
Agile Therapeutics
Post-IPO EquityFeb 2015$20M
Series CJul 2012$40M
$60M
Co-investors: Stacey Seltzer (Aisling Capital)
Miramar Labs
Series DOct 2014$26M
$46.3M
Co-investors: Hank Plain (Morgenthaler Ventures)
Zeltiq Aesthetics
Series DJun 2010$25M
$50.1M
Co-investors: Bryan Roberts (Venrock)
TransEnterix
Post-IPO EquityOct 2009$55M
$55M
Sirion Therapeutics
Series BApr 2007$45M
$45M
SkinMedica
Series DJul 2004$30M
$30M